- Home
- STRO vs CFSB Comparison
STRO vs CFSB Comparison
Compare STRO & CFSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- CFSB
- Stock Information
- Founded
- STRO 2003
- CFSB 1889
- Country
- STRO United States
- CFSB United States
- Employees
- STRO N/A
- CFSB 28
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- CFSB Major Banks
- Sector
- STRO Health Care
- CFSB Finance
- Exchange
- STRO Nasdaq
- CFSB Nasdaq
- Market Cap
- STRO 94.9M
- CFSB 93.3M
- IPO Year
- STRO 2018
- CFSB N/A
- Fundamental
- Price
- STRO $0.95
- CFSB $14.25
- Analyst Decision
- STRO Hold
- CFSB
- Analyst Count
- STRO 7
- CFSB 0
- Target Price
- STRO $1.97
- CFSB N/A
- AVG Volume (30 Days)
- STRO 1.6M
- CFSB 16.8K
- Earning Date
- STRO 11-10-2025
- CFSB 10-29-2025
- Dividend Yield
- STRO N/A
- CFSB N/A
- EPS Growth
- STRO N/A
- CFSB N/A
- EPS
- STRO N/A
- CFSB N/A
- Revenue
- STRO $104,473,000.00
- CFSB $7,612,000.00
- Revenue This Year
- STRO $65.48
- CFSB N/A
- Revenue Next Year
- STRO N/A
- CFSB N/A
- P/E Ratio
- STRO N/A
- CFSB N/A
- Revenue Growth
- STRO N/A
- CFSB N/A
- 52 Week Low
- STRO $0.52
- CFSB $6.41
- 52 Week High
- STRO $4.60
- CFSB $14.25
- Technical
- Relative Strength Index (RSI)
- STRO 45.59
- CFSB 62.63
- Support Level
- STRO $1.01
- CFSB $14.14
- Resistance Level
- STRO $1.20
- CFSB $14.24
- Average True Range (ATR)
- STRO 0.12
- CFSB 0.04
- MACD
- STRO -0.02
- CFSB -0.00
- Stochastic Oscillator
- STRO 8.09
- CFSB 100.00
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About CFSB CFSB Bancorp Inc.
CFSB Bancorp Inc is a savings and loan holding company of Colonial Federal Savings Bank (the Bank). Through the bank, it operates as a full-service banking organization, offering various financial and banking products and services. Its primary deposit products are savings, checking, and term certificate accounts, and its primary lending product is residential mortgage loans. The group's loan portfolio includes residential real estate, commercial real estate, construction, and consumer loan segments. Residential real estate loans include classes for one- to four-family, multi-family, second mortgages, and home equity lines of credit. Additionally, it also provides mobile banking, ATM/Debit cards, online banking, and other related services.